IDEXX Laboratories Inc. logo

IDEXX Laboratories (IDXX) stock

IDXX · IDEXX Laboratories Inc. · NASDAQ

$689.78-8.77 (-1.26%)today
Website
Market cap
$54.35B
P/E
46.5
EPS (TTM)
$14.84
Shares out
78.8M
Open
$694.16
Prev close
$698.56
VWAP
$690.17
52-week range70% up the range
$501.15$768.95

Today $687.16 - $694.16

Why is IDXX stock moving today?

IDXX fell 1.26% to $689.78 on Nov 19, 2026.

INSIDERago
Executive Chair of the Board Jonathan Jay Mazelsky gifted 700 shares, decreasing direct ownership by 0.84% to 83,103 units (SEC Form 4)

4 - IDEXX LABORATORIES INC /DE (0000874716) (Issuer)

All IDXX news
Price$689.78-8.77 (-1.26%)
02:30 PM08:45 PM

When does IDEXX Laboratories report earnings?

IDEXX Laboratories last reported on Nov 2, 2026, the date it announced on Oct 1, 2026. Before that it reported on Aug 4, 2026 and May 5, 2026. On that schedule the next report would come around early February 2027, with the date usually announced about 4 weeks ahead.

IDXX earnings history

Who owns the most IDXX stock?

BlackRock, Inc. was the largest reported holder of IDXX at the end of Q2 2026, with 8,170,178 shares worth $4.3 billion. Next came Vanguard Capital Management LLC ($2.7 billion) and Vanguard Portfolio Management LLC ($2.1 billion). In all, 1,300 institutions reported $39.2 billion of IDXX in their 13F filings.

All IDXX fund holders

Are insiders buying or selling IDXX?

Insiders are selling. In the last 90 days 5 insiders sold $28.6 million of IDXX in trades reported on Form 4. The latest: Sharon E. Underberg sold $6.1 million, reported on Nov 5, 2026.

IDXX insider trades

Financial highlights

Full financials
Revenue, TTM
$4.66B
Revenue growth
+11.9%
Net income, TTM
$1.18B
Net margin
25.4%
Free cash flow, TTM
$1.30B
Cash
$197.54M

For the twelve months ended Sep 30, 2026, from SEC filings. Not investment advice.

Latest news

25 items

Hiring

Nov 20, 2026

IDEXX Laboratories Inc. lists 229 open roles on its careers site as of Nov 20, 2026.

Open roles
229

Counted daily from IDEXX Laboratories Inc.'s careers site.

IDXX rankings

News · 26 weeks29+150%
2026-05-24: 12026-05-31: 22026-06-07: 02026-06-14: 02026-06-21: 02026-06-28: 12026-07-05: 02026-07-12: 02026-07-19: 02026-07-26: 12026-08-02: 42026-08-09: 12026-08-16: 02026-08-23: 12026-08-30: 12026-09-06: 12026-09-13: 22026-09-20: 02026-09-27: 22026-10-04: 02026-10-11: 22026-10-18: 02026-10-25: 02026-11-01: 82026-11-08: 12026-11-15: 1
2026-05-242026-11-15
Mix1990d
  • Insider9(47%)
  • Other3(16%)
  • Earnings2(11%)
  • Analyst2(11%)
  • SEC Filings2(11%)
  • M&A1(5%)
Activity · 52 weeks9455 active days
Tap a day to see what happenedEarningsInsiderAnalystFilings and news

Our reporting on IDXX

IDEXX Laboratories Inc. (IDXX) is a Biotechnology: In Vitro & In Vivo Diagnostic Substances company listed on NASDAQ. In the last 30 days Quantisnow tracked 10 wire items for IDXX, including 7 insider trades, 2 SEC filings and 1 earnings update. The most recent was published Nov 18, 2026.

IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; Livestock, Poultry and Dairy; and Other segments. It provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services for biomedical research community. The company also offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; and point-of-care electrolytes and blood gas analyzers and SARS-CoV-2 RT-PCR that are used in the human point-of-care medical diagnostics market; in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers; SNAP rapid assays test kits. In addition, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; veterinary software and services for independent veterinary clinics and corporate groups. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

IDXX FAQ

11 questions
  • What does IDEXX Laboratories Inc. do?
    IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; Livestock, Poultry and Dairy; and Other segments. It provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health...
  • What is IDXX revenue?
    IDEXX Laboratories Inc. (IDXX) reported $4.66B of revenue for the twelve months ended Sep 30, 2026. That is up 11.9% from the year before. Revenue for fiscal 2025 was $4.30B.
  • Is IDXX profitable?
    Yes. IDEXX Laboratories Inc. earned $1.18B in net income for the twelve months ended Sep 30, 2026, a net margin of 25.4%.
  • How much cash and debt does IDXX have?
    IDEXX Laboratories Inc. reported $197.54M in cash and cash equivalents and $374.88M of debt on its most recent balance sheet in SEC filings.
  • Is IDEXX Laboratories Inc. (IDXX) hiring?
    IDEXX Laboratories Inc. lists 229 open roles on its careers site as of Nov 20, 2026.
  • Where does IDXX stock trade?
    IDEXX Laboratories Inc. (IDXX) is listed on NASDAQ.
  • What sector and industry is IDXX in?
    IDEXX Laboratories Inc. operates in the Health Care sector, Biotechnology: In Vitro & In Vivo Diagnostic Substances industry.
  • When did IDEXX Laboratories Inc. go public?
    IDEXX Laboratories Inc. (IDXX) completed its IPO in 1991.
  • What are analysts saying about IDXX?
    Across the last 8 analyst actions on IDEXX Laboratories Inc., there was 1 upgrade and 0 downgrades. The most recent action was from Goldman: Buy with a $740.00 price target on 2026-10-16. Recent price targets range from $625.00 to $850.00.
  • What companies are similar to IDXX?
    Notable peers in the same industry include ZTS (Zoetis Inc.), ELAN (Elanco Animal Health Incorporated), TMO (Thermo Fisher Scientific Inc), NEOG (Neogen Corporation). Compare IDXX side-by-side with any of them on Quantisnow.
  • How can I track IDXX on Quantisnow?
    Quantisnow aggregates IDEXX Laboratories Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow IDXX to receive live email and push alerts on every new disclosure.

Is something on this page wrong, or out of date? Request a change